DCM
TMCI icon

Dupont Capital Management’s Treace Medical Concepts TMCI Stock Holding History

Dupont Capital Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16,822
Closed -$241K – 1675
2022
Q2 		$241K Hold
16,822
– – 0.01% 935
2022
Q1 		$318K Sell
16,822
-1,488
-8% -$28.9K 0.01% 909
2021
Q4 		$341K Buy
18,310
+446
+2% +$9.2K 0.01% 936
2021
Q3 		$481K Sell
17,864
-2,525
-12% -$69.5K 0.02% 908
2021
Q2 		$637K Buy
+20,389
New +$649K 0.02% 851

Other funds holding TMCI

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Dupont Capital Management's TMCI Position: Q3 2022 in Review

Dupont Capital Management sold out of Treace Medical Concepts (TMCI) in Q3 2022, closing a stake of 16,822 shares — an estimated $241K sold.

Dupont Capital Management first reported a position in TMCI in Q2 2021 and held it in 5 quarters. The position peaked at $637K in Q2 2021. 91 funds tracked by Wall St. Rank hold TMCI as of Q3 2022.

  • Dupont Capital Management reported no remaining Treace Medical Concepts position as of Q3 2022 after selling out during the quarter.
  • Dupont Capital Management sold 16,822 Treace Medical Concepts shares in Q3 2022, an estimated $241K.
  • Dupont Capital Management first reported a position in Treace Medical Concepts in Q2 2021 and held it in 5 quarters.
  • Dupont Capital Management's Treace Medical Concepts position peaked at $637K in Q2 2021.
  • 91 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2022.

Based on Dupont Capital Management's 13F filing for Q3 2022, filed 31 Oct 2022.